Anti-GDPD3 monoclonal antibody

Pre-made anti-GDPD3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GDPD3/GDPD3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0898-Ab-1/ GM-Tg-hg-IP0898-Ab-2Anti-Human GDPD3 monoclonal antibodyHuman
GM-Tg-rg-IP0898-Ab-1/ GM-Tg-rg-IP0898-Ab-2Anti-Rat GDPD3 monoclonal antibodyRat
GM-Tg-mg-IP0898-Ab-1/ GM-Tg-mg-IP0898-Ab-2Anti-Mouse GDPD3 monoclonal antibodyMouse
GM-Tg-cynog-IP0898-Ab-1/ GM-Tg-cynog-IP0898-Ab-2Anti-Cynomolgus/ Rhesus macaque GDPD3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0898-Ab-1/ GM-Tg-felg-IP0898-Ab-2Anti-Feline GDPD3 monoclonal antibodyFeline
GM-Tg-cang-IP0898-Ab-1/ GM-Tg-cang-IP0898-Ab-2Anti-Canine GDPD3 monoclonal antibodyCanine
GM-Tg-bovg-IP0898-Ab-1/ GM-Tg-bovg-IP0898-Ab-2Anti-Bovine GDPD3 monoclonal antibodyBovine
GM-Tg-equg-IP0898-Ab-1/ GM-Tg-equg-IP0898-Ab-2Anti-Equine GDPD3 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0898-Ab-1/ GM-Tg-hg-IP0898-Ab-2; GM-Tg-rg-IP0898-Ab-1/ GM-Tg-rg-IP0898-Ab-2;
GM-Tg-mg-IP0898-Ab-1/ GM-Tg-mg-IP0898-Ab-2; GM-Tg-cynog-IP0898-Ab-1/ GM-Tg-cynog-IP0898-Ab-2;
GM-Tg-felg-IP0898-Ab-1/ GM-Tg-felg-IP0898-Ab-2; GM-Tg-cang-IP0898-Ab-1/ GM-Tg-cang-IP0898-Ab-2;
GM-Tg-bovg-IP0898-Ab-1/ GM-Tg-bovg-IP0898-Ab-2; GM-Tg-equg-IP0898-Ab-1/ GM-Tg-equg-IP0898-Ab-2
Products NameAnti-GDPD3 monoclonal antibody
Formatmab
Target NameGDPD3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GDPD3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0898-Ag-1Recombinant multi-species GDPD3/ GDE7 protein


    Target information

    Target IDGM-IP0898
    Target NameGDPD3
    Gene ID79153,68616,293490,708824,100855729,101080853,767913,100146273
    Gene Symbol and Synonyms1110015E22Rik,GDE7,GDPD3,RGD1308386
    Uniprot AccessionQ7L5L3
    Uniprot Entry NameGDPD3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000102886
    Target ClassificationN/A

    The target: GDPD3, gene name: GDPD3, also named as GDE7. Enables phosphoric diester hydrolase activity. Involved in N-acylethanolamine metabolic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.